Botanix Pharmaceuticals (ASX:BOT) Price-to-Tangible-Book

: 15.77 (As of Today)

View and export this data going back to 1985. Start your Free Trial

As of today (2024-04-16), Botanix Pharmaceuticals's share price is A$0.205. Botanix Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.01. Hence, Botanix Pharmaceuticals's Price to Tangible Book Ratio of today is 15.77.

The historical rank and industry rank for Botanix Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

ASX:BOT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.11 Med: 4.19 Max: 180
Current: 20.5

During the past 13 years, Botanix Pharmaceuticals's highest Price to Tangible Book Ratio was 180.00. The lowest was 1.11. And the median was 4.19.

ASX:BOT's Price-to-Tangible-Book is ranked worse than
95.58% of 1222 companies
in the Biotechnology industry
Industry Median: 2.75 vs ASX:BOT: 20.50

A closely related ratio is called PB Ratio. As of today, Botanix Pharmaceuticals's share price is A$0.205. Botanix Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.03. Hence, Botanix Pharmaceuticals's P/B Ratio of today is 7.07.

Botanix Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Botanix Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

180.00

1.67

3.81

11.40

14.44

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book																3.73	11.40	7.57	14.44	14.62

Competitive Comparison

For the Biotechnology subindustry, Botanix Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Botanix Pharmaceuticals Price-to-Tangible-Book Distribution

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's Price-to-Tangible-Book falls into.

Botanix Pharmaceuticals Price-to-Tangible-Book Calculation

Botanix Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.205	/	0.013
	=	15.77

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Botanix Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines